FDA Inspection 1140901 — Incyte Corporation
The FDA completed an inspection of Incyte Corporation on April 16, 2021 in Wilmington, DE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 16, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wilmington, DE (United States)
Additional Details
Sponsor, Contract Research Organization